15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 10 firms covering Quest Diagnostics Incorporated, 4 rate it Buy or better, 6 sit at Hold, and 0 rate it Sell or worse, a hold consensus. Targets are tightly clustered, $200.00 to $260.00, so the covering firms are broadly aligned. The average target of $230.20 sits 2% below the current $235.95. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $2.66 next quarter toward $11.94 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS10 ratings
Hold
Strong Buy00%
Buy440%
Hold660%
Sell00%
Strong Sell00%
Based on 10 analysts giving stock ratings to Quest Diagnostics Incorporated.
As of Jul, 4 of 10 firms rate DGX a Buy (6 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
DGX EPS & revenue forecast
EPS · NEXT QUARTER
$2.66
Range $2.51 – $2.74 · 14 analysts · +10% YoY
Next period, 14 analysts expect Quest Diagnostics Incorporated to earn $2.66 a share (range $2.51 – $2.74), versus $2.42 a year earlier. Full-year consensus is $11.07, growing to $11.94 the year after.
REVENUE · NEXT QUARTER
$3.0B
Range $2.9B – $3.1B · 14 analysts · +7% YoY
Revenue is expected to reach $3.0B (range $2.9B – $3.1B), +7.2% year-over-year. Full-year consensus is $12.0B, rising to $12.5B next year.
Top analysts covering Quest Diagnostics Incorporated
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on DGX.
#1
DM
David Macdonald
Truist Securities · Rank #67
Hold
$250.00+6.0% to target
Overall win rate
51%
+ Follow
#2
Luke Sergott
Barclays · Rank #194
Buy
$250.00+6.0% to target
Overall win rate
41%
+ Follow
#3
David Westenberg
Piper Sandler · Rank #227
Hold
$200.00-15.2% to target
Overall win rate
31%
+ Follow
#4
Patrick Donnelly
Citigroup · Rank #260
Hold
$215.00-8.9% to target
Overall win rate
32%
+ Follow
#5
Kevin Caliendo
UBS
Hold
$232.00-1.7% to target
Coverage
—
+ Follow
DGX stock forecast FAQ
What is DGX's average 12-month price target?+
The 10 analysts with a live target average $230.20 for Quest Diagnostics Incorporated over the next 12 months, ranging from a $260.00 high to a $200.00 low.
Is DGX stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 10 analyst ratings, 4 are Buy or Strong Buy, 6 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for DGX?+
The Street-high target is $260.00 (Mizuho), and the Street-low is $200.00 (Piper Sandler). The average of all 10 active targets is $230.20.
How many Wall Street analysts cover DGX?+
10 analysts have an active rating on Quest Diagnostics Incorporated, and 10 firms carry a live 12-month price target.
Who is the most accurate analyst covering DGX?+
Among analysts who currently cover DGX, David Macdonald of Truist Securities has the strongest overall Quantellect track record (Rank #67). Their current call is Hold with a $250.00 target.
What is Quest Diagnostics Incorporated's projected EPS for next quarter?+
The consensus estimate is $2.66 per share (range $2.51 – $2.74) across 14 analysts. Full-year EPS is projected at $11.07, rising to $11.94 the following year.
How much revenue is Quest Diagnostics Incorporated expected to report next quarter?+
Consensus revenue is $3.0B (range $2.9B – $3.1B). Full-year revenue is projected at $12.0B, growing to $12.5B next year.
Have analysts been upgrading or downgrading DGX lately?+
As of Jul, 4 of 10 firms rate DGX a Buy (6 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their DGX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
